World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
16418
World Ranking
3115
National Ranking
1459

Michael C. Sneller publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael C. Sneller sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 161 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael C. Sneller D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael C. Sneller sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael C. Sneller is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their work predominantly centers on the fields of Medicine and Immunology and Microbiology, with a significant focus on infectious diseases, virology, immunology, neurology, and clinical psychology.

Their research covers several main topics, including:

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Viral Infections and Outbreaks Research
  • Long-Term Effects of COVID-19
  • COVID-19 and Mental Health
  • Immune Cell Function and Interaction

Michael C. Sneller has published multiple academic papers, some of which include:

  • "Prolonged viral suppression with anti-HIV-1 antibody therapy" (2022) published in Nature
  • "A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings" (2022) published in Annals of Internal Medicine
  • "Combination anti-HIV antibodies provide sustained virological suppression" (2022) published in Nature
  • "Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy" (2021) published in Nature Medicine
  • "Early human B cell signatures of the primary antibody response to mRNA vaccination" (2022) published in Proceedings of the National Academy of Sciences

Their research frequently appears in publication venues such as:

  • The Journal of Infectious Diseases
  • Nature
  • Annals of Internal Medicine
  • Nature Medicine
  • AIDS

Michael C. Sneller has collaborated extensively with several co-authors, including:

  • Tae-Wook Chun
  • Susan Moir
  • Victoria Shi
  • J. Shawn Justement
  • Jana Blažková

Best Publications

  • Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

    Kevin C. Conlon;Enrico Lugli;Hugh C. Welles;Hugh C. Welles;Steven A. Rosenberg

  • Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II

    Jin Wang;Lixin Zheng;Adrian Lobito;Francis Ka Ming Chan

  • Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis

    C Talar-Williams;Y M Hijazi;M M Walther;W M Linehan

  • HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

    M Connors;J A Kovacs;S Krevat;J C Gea-Banacloche

  • The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

    Stephen E. Straus;Elaine S. Jaffe;Jennifer M. Puck;Janet K. Dale

  • Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

    Katharine J Bar;Michael C Sneller;Linda J Harrison;J Shawn Justement

  • Clinical, Immunologic, and Genetic Features of an Autoimmune Lymphoproliferative Syndrome Associated With Abnormal Lymphocyte Apoptosis

    Michael C. Sneller;Jin Wang;Janet K. Dale;Warren Strober

  • A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

    M C Sneller;S E Straus;E S Jaffe;J S Jaffe

  • An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.

    Stephen E. Straus;Michael Sneller;Michael J. Lenardo;Jennifer M. Puck

  • Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.

    Anuoluwapo Osinusi;Eric G. Meissner;Yu Jin Lee;Dimitra Bon

  • An analysis of forty‐two wegener's granulomatosis patients treated with methotrexate and prednisone

    Michael C. Sneller;Gary S. Hoffman;Cheryl Talar-Williams;Gail S. Kerr

  • Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis

    Carol A. Langford;Michael C. Sneller;Claire W. Hallahan;Gary S. Hoffman

  • Reactivation of Latent Epstein–Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas

    Wen Hai Feng;Jeffrey I. Cohen;Steven Fischer;Li Li

  • Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature.

    Philip E. Tarr;Michael C. Sneller;Laura J. Mechanic;Athena Economides

  • Pathological Findings in Human Autoimmune Lymphoproliferative Syndrome

    Megan S. Lim;Stephen E. Straus;Janet K. Dale;Thomas A. Fleisher

  • A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitis

    Michael C. Sneller;Zonghui Hu;Carol A. Langford

  • Active Wegener’s Granulomatosis Is Associated with HLA-DR+ CD4+ T Cells Exhibiting an Unbalanced Th1-Type T Cell Cytokine Pattern: Reversal with IL-10

    Björn R. Lúdvíksson;Michael C. Sneller;Kevin S. Chua;Cheryl Talar-Williams

  • New Insights into Common Variable Immunodeficiency

    Michael C. Sneller;Warren Strober;Eli Eisenstein;Jonathan S. Jaffe

  • Autoimmune Lymphoproliferative Syndrome with Defective Fas: Genotype Influences Penetrance

    Christine E. Jackson;Roxanne E. Fischer;Amy P. Hsu;Stacie M. Anderson

  • Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques.

    Thomas A. Waldmann;Enrico Lugli;Mario Roederer;Liyanage P. Perera

Frequent Co-Authors

Anthony S. Fauci
Anthony S. Fauci Georgetown University
Warren Strober
Warren Strober National Institute of Allergy and Infectious Diseases
H. Clifford Lane
H. Clifford Lane National Institute of Allergy and Infectious Diseases
Tae-Wook Chun
Tae-Wook Chun National Institute of Allergy and Infectious Diseases
Sharon E. Straus
Sharon E. Straus University of Toronto
Susan Moir
Susan Moir National Institute of Allergy and Infectious Diseases
Thomas A. Fleisher
Thomas A. Fleisher National Institutes of Health
Jennifer M. Puck
Jennifer M. Puck University of California, San Francisco
James H. Shelhamer
James H. Shelhamer National Institutes of Health
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Nursing is a popular pathway, with many opting for a Family Nurse Practitioner (FNP) program. If you want a smoother transition, consider the easiest fnp program, which offers streamlined coursework and flexible online learning.

Mental health is another growing field closely connected to immunological research, especially in neuroimmunology. For aspiring psychiatric professionals, top programs are available—particularly those focusing on mental health nurse practitioner roles. Check out the top psychiatric mental health nurse practitioner programs online to find quality education paired with strong clinical placements.

Cost is a significant factor for many students. If budget constraints are a concern, some of the cheapest psychiatric nurse practitioner programs provide an affordable pathway without sacrificing educational quality.

Advanced degrees, such as a Doctor of Nursing Practice (DNP), offer higher earning potential. For insight into financial prospects, review the doctorate in nursing salary by state to understand regional variations and plan your career accordingly.

Best Scientists Citing Michael C. Sneller

Trending Scientists

Recently Published Articles